The aberrant accumulation of nucleolin has been reported to be associated with several cancers including prostate [10], breast [11], glioblastomas [12], pancreatic [13], and hepatocellular carcinoma [14]. This evidence concerns the gene NUCLEOLIN and hepatocellular carcinoma.